| Study title: |
Help Prevent Adverse Reactions to Medications
|
| Principal investigator: |
Lewis, Tamorah |
| Study description: |
The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) aims to help solve the drug safety problem by developing genetic tests that predict which patients are at risk for a serious adverse drug reaction. This will allow doctors to prescribe drugs based on a patient’s genetic profile: the right drug at the right dose for each child. CPNDS researchers are based in all the major children’s hospitals across Canada. The researchers are collecting patient DNA samples, analyzing genes, and comparing patient reactions to various medications. |
| Recruitment information: |
We are looking for any child or teenager under 19 years of age, who has experienced a serious side effect or reaction to a medication. If you are interested in participating in this study, please contact us and we will meet with you once during your next routine clinical visit at SickKids. During the meeting we will ask you some questions about your/your child's medication history and take a small saliva sample of you/your child. It will take about 15 minutes of your time. |
| Enrollment status: |
Closed
|
| Contact name: |
Smita Karande |
| Telephone: |
(416)8137654 ext205675 |
| Email: |
smita.karande@sickkids.ca |
